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Human limb muscle and skin blood ﬂow increases signiﬁcantly with elevations in temperature,
possibly through physiological processes that involve temperature-sensitive regulatory
mechanisms. Here we tested the hypothesis that the release of the vasodilator ATP from human
erythrocytes is sensitive to physiological increases in temperature both in vitro and in vivo,
andexaminedpotentialchannel/transportersinvolved.ToinvestigatethesourceofATPrelease,
whole blood, red blood cells (RBCs), plasma and serum were heated in vitro to 33, 36, 39 and
42◦C. In vitro heating augmented plasma or ‘bathing solution’ ATP in whole blood and RBC
samples, but not in either isolated plasma or serum samples. Heat-induced ATP release was
blocked by niﬂumic acid and glibenclamide, but was not affected by inhibitors of nucleoside
transport or anion exchange. Heating blood to 42◦Ce n h a n c e d( P<0.05) membrane protein
abundanceofcysticﬁbrosistransmembraneconductanceregulator(CFTR)inRBCs.Inaparallel
in vivo study in humans exposed to whole-body heating at rest and during exercise, increases
in muscle temperature from 35 to 40◦C correlated strongly with elevations in arterial plasma
ATP (r2 =0.91; P =0.0001), but not with femoral venous plasma ATP (r2 =0.61; P =0.14).
In vitro, however, the increase in ATP release from RBCs was similar in arterial and venous
samples heated to 39◦C. Our ﬁndings demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature, possibly via activation of CFTR-like channels, and
suggest that temperature-dependent release of ATP from erythrocytes might be an important
mechanism regulating human limb muscle and skin perfusion in conditions that alter blood
and tissue temperature.
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Internal body temperature is a highly regulated
physiologicalprocessinhumansandotherhomeothermic
animals. However, large regional differences in
temperature still exist between internal organs and
limb tissues, with the latter being 2–5◦Cl o w e ri n
humans and larger animals in normal resting conditions
(Bazett & McGlone, 1927; He et al. 2002). These
temperature differences are also highlighted during
exercise, when the temperature of the blood and
muscle of the exercising limbs can increase from 33–
35 to 40–41◦C while in non-exercising limbs it remains
essentially unchanged (Saltin et al. 1972; Gonz´ alez-
Alonso et al. 1999a,b). Hence, RBCs can be exposed to
drastic changes in temperature as they travel through
tissues with different metabolic heat production and
haemodynamic demands. Although recent evidence in
heat-stressedhumanssupportsacloseassociationbetween
the elevations in limb tissue perfusion and the increases
in muscle temperature and arterial plasma adenosine 5 -
triphosphate (ATP; Pearson et al. 2011), the ATP source
and temperature-sensitive mechanisms involved remain
unknown.
The erythrocytes, the major oxygen carriers in the
blood, have been hypothesized to play a crucial role
in the control of local tissue blood ﬂow. According
to the hypothesis proposed by Ellsworth et al. (1995),
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when the erythrocytesencounteran area where metabolic
demands are augmented a signalling mechanism coupled
to the ofﬂoading of oxygen is triggered, resulting in the
release of ATP from the erythrocytes into the vascular
lumen. The ATP acts upon the endothelial P2y receptors,
triggeringthereleaseofnitricoxide,prostaglandinsand/or
endothelium-derived hyperpolarizing factor, which in
turn act upon the surrounding smooth muscle cells to
cause vasodilatation (Ellsworth et al. 1995; Sprague et al.
1996; Mortensen et al. 2009a,b). The release of ATP from
erythrocytescanoccurnotonlyinresponsetoareduction
in PO2, but also in response to blood cell deformation
(Spragueetal.1998;Fischeretal.2003).Theendothelium
could be another source of ATP; however, catabolic
ectonucleotidases (Zimmermann, 2006b) present on
the surface of cellular membranes (Gordon, 1986;
Zimmermann, 2006a) immediately convert intravascular
ATP to adenosine, thereby evoking P1 receptor-mediated
vasodilatation (Deussen et al. 1986). It has long been
known that an increase in temperature reduces the
afﬁnity of haemoglobin for oxygen (Barcroft & King,
1909; Duc & Engel, 1969). This suggests that temperature
has the potential to modulate the release of ATP from
erythrocyte directly or indirectly; however, no study to
date has systematically investigated whether temperature
per se is a major stimulus for the release of ATP from
erythrocytes.
The mechanisms of ATP release from erythrocytes are
thought to involve membrane-bound ion channels, gap
junction proteins, such as pannexin1, and/or members of
theATP-bindingcassetteproteins(ABCproteins),suchas
the cystic ﬁbrosis transmembrane conductance regulator
(CFTR; Bergfeld & Forrester, 1992; Abraham et al. 1993;
Locovei et al. 2006). The impact of temperature on
thesechannels/transportersisnotknown.Themembrane-
bound ion channel known as band3 (also known as the
anion exchanger AE1) was the ﬁrst channel proposed
to regulate the release of ATP from erythrocytes with
exposure to hypoxia (Bergfeld & Forrester, 1992). More
recently, the gap junction protein pannexin1, which
is also abundantly expressed in erythrocytes, has been
postulatedtoformATP-permeablechannelsintheplasma
membrane, and responds to low oxygen tension through
its action on the signal transduction pathway leading
to ATP release (Locovei et al. 2006; Sridharan et al.
2010). Lastly, the CFTR channels in erythrocytes and
other cells have been shown to be activated by external
physiological stimuli, such as cell deformation, cell
swelling and changes in pH (Sprague et al. 1998; Gourine
et al. 2010; Tu et al. 2010). Whether the aforementioned
channels/transporters are involved in the release of ATP
fromerythrocyteswhentemperatureisincreasedhasnever
been examined.
The main purpose of this study, therefore, was to
investigate the source and the temperature-sensitive
mechanismofATPreleaseinhumanblood.Toaccomplish
this overall aim, the following investigations were carried
out: (i)whole blood and its separate constituents were
heated in vitro to establish the primary source of ATP;
(ii)speciﬁc and non-speciﬁc channel inhibitors were used
to block in vitro ATP release from human erythrocytes to
understand the mechanism of heat-induced ATP release;
(iii)blood samples from healthy volunteers exposed to
heat stress in resting and exercising conditions were
assessed to examine whether ATP release was comparable
to the response observed in our in vitro experiments; and
(iv)arterial and venous blood was heated in vitro to assess
whether the oxygenation status of the blood affects the
amount of ATP release. We hypothesize that the release of
ATPfromhumanerythrocytesissensitivetophysiological
increases in temperature per se,b o t hin vitro and in vivo,
and that channels localized in the erythrocyte membrane
a r ei n v o l v e di nt h i sp r o c e s s .
Methods
This study, consisting of ﬁve in vitro protocols and one in
vivo protocol (i.e. protocols1–6) conformed to the code
of Ethics of the World Medical Association (Declaration
of Helsinki) and was conducted after receiving ethical
approval from the Brunel University Research Ethics
Committee. Informed written and verbal consent was
obtained from all of the participants before commencing
with any part of this study. Subjects were asked to refrain
fromexerciseandingestionofcaffeineonthedayofblood
withdrawal.
Blood samples for the in vitro heating protocols1–
4 were obtained by venepuncture of an antecubital
vein in 27 healthy men ranging in age from 21 to
46years (mean±SD age 28±7 years) and were tested
on the day of collection (within 30–50min of blood
collection). Blood was always collected in a syringe and
immediatelyaliquotedintoK3-EDTAorserumseparation
t u b e s .F o rp r o t o c o l 5 ,1 0h e a l t h yr e c r e a t i o n a l l ya c t i v e
men (mean±SD age 21±2years) participated in a
graded whole-body heating protocol, which has been
described in detail previously (Pearson et al. 2011).
Only during this protocol, arterial and venous blood
samples were assayed immediately after collection. In
protocol6, arterial and venous blood was collected from
four subjects (mean±SD age 31±6years) in a syringe
and immediately aliquoted into K3-EDTA. The red blood
cells (RBCs) were then heated in vitro.
Protocol 1: effect of heating on ATP release from
blood constituents in vitro
The main aim of this protocol was to determine the
source of ATP by heating whole blood and the separate
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constituents of blood. Blood was collected from 10
individuals for this part of the study. Blood collected in
EDTA tubes was separated into eppendorf tubes and kept
as whole blood or centrifuged at 15,493g for 30s at room
temperature. Plasma was removed and transferred into
new tubes; the buffy coat was removed and discarded,
whiletheRBCfractionwasalsokeptforexperimentation.
The volume was restored by adding physiological saline
after plasma and buffy coat removal from the RBC
fraction. Tubes used for serum separation were coated
with silicon and micronized silica particles to accelerate
clotting (SSTII advance serum separation tubes; Becton
& Dickinson, Oxford, UK). Blood was allowed to clot for
30min at room temperature, and serum was collected
aftercentrifugationfor10minat1000g.Aliquots(0.5ml)
of whole blood, RBCs, plasma and serum were heated
for 20min (Baar, 1967) in stirred water baths set at
33 (control), 36, 39 and 42◦C. Prior to the heating
protocol, initial levels of ATP and free haemoglobin were
measured. To further determine the effects of heating
on whole blood haematological parameters, RBC count,
total haemoglobin, haematocrit, mean cell volume, mean
cell haemoglobin and mean corpuscular haemoglobin
concentration were measured using an automatic
haematology analyser (Sysmex KX-21N; Sysmex UK Ltd,
Milton Keynes, UK) after repeated blood samples from
one individual were incubated for 20min at 33, 36, 39
and 42◦C.
Protocol 2: time course for in vitro heat-dependent
erythrocyte ATP release
The aim of this protocol was to ascertain the time course
of the increase in ATP release from human erythrocytes
with heating over 20min. Tubes with RBCs were initially
placed in a water bath set at 33◦C, where the temperature
was continuously monitored by a thermocouple inserted
into a tube containing RBCs. Once the temperature was
stable at 33◦C for ∼5min, a set of tubes containing RBCs
were moved to a water bath maintained at 42◦C. Another
tube containing RBCs with a second thermocouple was
used to indicate the time needed to reach 42◦C starting
from 33◦C. Samples were removed from the water baths
s e ta t3 3a n d4 2 ◦C after 1, 3, 5, 10, 15 and 20min. At each
time point, the temperature was noted and samples were
rapidly prepared for ATP analysis. Data were collected
from six to 10 healthy individuals.
A further set of RBC samples (n=6) wer e heated
to 42◦C for 20min and then moved to a water
b a t hs e ta t3 3 ◦C. Samples were removed at regular
intervals for ATP analysis. Release of ATP was compared
with control samples kept at 33◦C. In these sets of
experiments, the number of RBCs was counted using a
haemocytometer for samples before and after 20min of
heating.
Protocol 3: effect of inhibitors of ATP channels and
transporters on heat-dependent erythrocyte ATP
release
Inordertodistinguishthepotentialchannelortransporter
involved in the heat-dependent ATP release from
erythrocytes, various inhibitors were used to block the
release during in vitro heating. Isolated RBCs were
incubated for 20min in water baths set at 33 (control)
and 39◦C with various inhibitors of band3 and band4.5.
The inhibitors used to block band3 transport included
niﬂumicacid,whichwasdissolvedinphysiological(0.9%)
saline, and DIDS, dissolved in 2% DMSO. The inhibitor
used to block band4.5 nucleoside translocation was
nitrobenzylthioinosine (NBTI) dissolved in DMSO. Stock
solutions of inhibitors were prepared so that the ﬁnal
concentration of DMSO was less than 1% and did not
induce haemolysis.
Red blood cells isolated from arterial and venous blood
samples, collected during protocol6, were incubated for
20min in water baths set at 33 (control) and 39◦C with
400μmoll−1 niﬂumicacidor400μmoll−1 glibenclamide
(an ATP-sensitive potassium channel blocker which
also blocks CFTR; Sheppard & Robinson, 1997).
Glibenclamide was prepared as a 0.01moll−1 stock
solutionin0.1 NNaOH and 50 mg ml−1 dextrosesolution
a n dh e a t e da t5 2 ◦Ct od i s s o l v e( S p r a g u eet al. 1998). The
effect of vehicle alone was also tested. All chemicals were
purchased from Sigma-Aldrich (Gillingham, UK).
Protocol 4: effect of in vitro heating on CFTR
abundance in erythrocyte ghost membrane isolation
The purpose of this protocol was to investigate whether
CFTR protein in the membranes of erythrocytes was
involved in the heat-dependent release of ATP. Human
red blood cell ghost membranes were prepared from
RBCs according to the method of Sterling et al. (2004)
after they were exposed to 33 and 42◦C for 20min.
The puriﬁed RBC membranes were dissolved using
50mmoll−1 Tris–HCl (pH7.5), 150mmoll−1 NaCl, 1%
TritonX-100and1%NonidetP-40plusproteaseinhibitor
cocktail. For the enzyme-linked immunosorbent assay
(ELISA), a microtitre 96-well plate was coated with
the dissolved membrane extracts in carbonate buffer
(15mmoll−1 Na2CO3 and35mmoll−1 NaHCO3,pH9.6)
and incubated overnight at 4◦C. Blocking buffer of 2%
bovine serum albumin in PBS was added and incubated
for 1h at 37◦C. After washing with PBS, wells were
incubatedwithrabbitpolyclonalantibodiesraisedagainst
the amino terminus of human CFTR diluted 1:2000
in PBS (New England Biolabs, Hitchin, UK) for 1h
at 37◦Ca n d2 ha t4 ◦C. After washing with 0.02%
Tween20 in PBS, wells were treated with human anti-
proteinA conjugated to horseradish peroxidase (Sigma)
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diluted to 1:3000 in PBS and incubated at 37◦C for 1h.
The reaction was developed using o-phenylenediamine
dihydrochloride(SigmaFASTTM).Ghostmembraneswere
prepared from blood taken from six subjects, and the
ELISA was carried out as an average of three repetitions.
Bovine serum albumin alone was used as a negative
control to test the speciﬁcity of the CFTR antibody. Total
protein was determined by the bicinchoninic acid assay
(Sigma).
Procotol 5: effect of heating on intravascular ATP in
vivo
To gain an insight regarding the effect of heating on
intravascular ATP release in vivo, blood samples collected
from subjects undergoing graded whole-body heating
wereassayedimmediatelyaftercollection.Inbrief,muscle
temperature and blood samples were obtained at rest and
after6minofmoderateone-leggedknee-extensorexercise
(mean±SEM, 21±1W) in the following four different
thermal conditions while wearing a water-perfused suit:
(i)control; (ii)mild heating; (iii)moderate heating; and
(iv)severe heating. Catheters were inserted into the
femoralveinoftheexercisingleg(leftleg)andintheradial
artery(rightforearm)usingtheSeldingertechniqueunder
localanaesthesia(1%lidocaine,HamelnPharmaceuticals,
Gloucester, UK). Quadriceps muscle temperature was
measuredinrealtime(TC-2000;SableSystems,LasVegas,
NV,USA)withaT-204Atissue-implantablethermocouple
microprobe (Physitemp, Clifton, NJ, USA). Arterial and
venous blood samples were collected in tubes containing
stop solution (for details see section below on ‘Blood
sample treatment’) at rest and at 5min of exercise during
each experimental condition.
Protocol 6: effect of in vitro heating on
heat-dependent erythrocyte ATP release from arterial
and venous blood samples
The aim of this protocol was to determine any differences
in ATP release from arterial and venous erythrocytes
exposed to in vitro heating. Subjects rested in a supine
position while two catheters were inserted as described
in the previous subsection; one was placed into the
radial artery of the right arm and the other into the
median cubital vein of the left arm. Arterial and venous
blood samples were collected in EDTA tubes. The RBCs
were immediately isolated by centrifuging whole blood at
15,493g for30satroomtemperaturefollowedbyremoval
of plasma. The samples were then subjected to the in vitro
heating protocol in water baths set at 33 and 39◦C for
20min. Blood haemoglobin oxygen saturation and PO2
were measured immediately upon collection in separate
samplesusingabloodgasanalyser(ABL825;Radiometer,
Copenhagen, Denmark).
Blood sample treatment
Blood samples (2ml) obtained during the in vivo
experiment (protocol5) were collected directly in
stop solution (2.7ml) containing S-(4-nitrobenzyl)-
6-thioinosine (NBTI; 5nmoll−1), 3-isobutyl-1-
methylxanthine (IBMX; 100μmoll−1), forskolin
(10μmoll−1), EDTA (4.15mmoll−1), NaCl
(118mmoll−1), KCl (5mmoll−1) and tricine buffer
(40mmoll−1) developed by Gorman et al. (2003). This
stopsolutionpreventsanyfurtherreleaseandmetabolism
of ATP, and values have been shown to remain stable
for ∼30min (Gorman et al. 2003, 2007). Blood samples
were weighed to enable precise calculation of the blood
volumes and determine the dilution factor for the ATP
concentration.Tosamplesundergoingtheinvitroheating
protocol, stop solution was added after 20min of heating.
Sampleswereimmediatelycentrifugedfor30sat15,493g,
and the supernatant was transferred into new tubes for
ATP and haemoglobin determination.
Measurement of ATP and haemoglobin
The ATP was determined with the luciferin–luciferase
technique, using a luminometer with three automatic
injectors (Orion Microplate Luminometer; Berthold
Detection System GmbH, Pforzheim, Germany). ATP
in the supernatant was measured in duplicate at room
temperature (20–22◦C) using an ATP kit (ATP Kit SL;
BioThema AB, Dalar¨ o, Sweden) with an internal ATP
standard procedure. According to the manufacturer,
free haemoglobin does not interfere with the analysis,
and the minimum detectable concentration of ATP
is 10−12 moll−1, while the maximum is 10−6 moll−1.
Haemoglobin was measured to estimate the degree of
haemolysis by reading the absorbance of the supernatants
at 560, 577 and 593nm (Cripps, 1968) with a
spectrophotometer (Jenway 3500; Bibby Scientiﬁc, Stone,
UK).Haemoglobinconcentration(ingramsperlitre)was
calculated from the absorbances (A)b y{177.6×[A577 –
(A560 +A593)/2]},where177.6isthecalibrationcoefﬁcient
k (Malinauskas, 1997). The effect of temperature on
haematocrit was assayed by incubating whole blood
for 20min in the different water baths, at the end of
which the haematocrit was determined in duplicate by
microcentrifugation (Dill & Costill, 1974).
Statistical analysis
A one-way repeated-measures ANOVA was performed
on all dependent variables to test signiﬁcance among
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the initial and heating conditions. When a signiﬁcant
difference (P<0.05) was found, appropriate post hoc
analysis was conducted (i.e. Tukey’s HSD test) using a
Bonferroni correction when the data were not normally
distributed (P<0.0125). Correlation between muscle
temperature and plasma ATP was determined using
Pearson’s product–moment correlation.
Results
Effect of increases in temperature on ATP release
from blood constituents in vitro
Whole blood heated for 20min at 39 and 42◦Cr e l e a s e d
signiﬁcantly more ATP than at 33◦C, increasing from
1.10±0.08 to 1.61±0.20 and 1.66±0.12μmoll−1,
respectively (P<0.05; Fig.1A). When compared with the
initial levels, ATP release was signiﬁcantly elevated at all
temperatures ≥36◦C. Moreover, a close correlation was
observedbetweenATPreleaseandwaterbathtemperature
(r2 =0.86; P =0.074).
When the RBC fraction alone was heated, the
magnitude of ATP release compared with whole blood
heated at the same temperatures was more than twofold
higher (Fig.1B). The ATP release from RBCs increased
progressively and signiﬁcantly from 0.79±0.11μmoll−1
at 33◦C to 3.54±0.47μmoll−1 at 42◦C( r2 =0.96;
P =0.021). To demonstrate that the ATP was released
from RBCs and not from any other blood constituents
contained within the sample, RBCs were also prepared by
washing three times in a buffered solution as described by
Olearczyketal.(2004).Afterheating,asimilarcorrelation
was demonstrated, where ATP release was augmented
with increasing temperature from 1.18±0.23μmoll−1 at
33◦Cto3.69±0.75μmoll−1at42◦C(r2 =0.93;P =0.033;
data not shown). In contrast, no changes were apparent
in plasma samples, and ATP levels were signiﬁcantly
lower than in either whole blood or RBC samples
(Fig.1C).
HeathadtheoppositeeffectonATPreleasefromserum,
as ATP levels declined signiﬁcantly in the heated serum
samples compared with initial levels. Moreover, the ATP
concentration in serum samples was signiﬁcantly lower
compared with initial levels found in whole blood, RBC
or plasma (Fig.1D). When considered collectively, the
initialstartingATPlevelswere∼1μmoll−1inwholeblood
andRBCs,∼0.5μmoll−1 inplasmaand∼0.2μmoll−1 in
serum. With heating to 42◦C, ATP release nearly doubled
in whole blood, increased by nearly fourfold in RBCs,
remained unchanged in plasma and decreased by 10-fold
in serum.
Free haemoglobin concentration remained unchanged
withincreasingtemperatureinwholeblood,RBC,plasma
or serum samples (P ranged from 0.48 to 0.98; Table1).
Likewise, whole blood haemotological responses also
Figure 1. Initial ATP and the effect of increasing temperature
on whole blood (A), erythrocytes (B), plasma (C)a n ds e r u m( D)
Open bar, initial starting ATP (n = 7–12); ﬁlled bars, ATP release
after heating for 20 min (n = 7–10). Data are shown as
means ± SEM.
∗
Signiﬁcantly different from 33◦C (control),
P < 0.05. # Signiﬁcantly different from 36◦C, P < 0.05.
† Signiﬁcantly different from initial, P < 0.05.
C   2012 The Authors. Experimental Physiology C   2012 The Physiological Society424 K. K. Kalsi and J. Gonz´ alez-Alonso Exp Physiol 97.3 (2012) pp 419–432
Table 1. Free haemoglobin levels in bathing solution after heating the different components of
blood
Initial 33◦C3 6 ◦C3 9 ◦C4 2 ◦C
Free haemoglobin (g l−1)
Whole blood 0.14 ± 0.01 0.20 ± 0.02 0.22 ± 0.03 0.23 ±0.03 0.25 ± 0.03
Erythrocytes 0.18 ± 0.05 0.15 ± 0.02 0.14 ± 0.02 0.15 ± 0.02 0.17 ± 0.03
Plasma 0.07 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 0.07 ± 0.01
Serum 0.03 ± 0.002 0.03 ±0.001 0.03 ± 0.002 0.03 ± 0.002 0.03 ± 0.001
Data are shown as means ± SEM of n = 7–10.
remained unaltered after incubation for 20min at 33, 36,
39 and 42◦C( T a b l e2 ) .
Time course of the temperature-dependent release of
ATP from human erythrocytes
The temperature of the RBC solution increased from
33.0±0.2 to 41.3±0.2 and 42.0±0.1◦Ca f t e r1a n d
3min and remained at ∼42◦C for the remaining 15min
incubation period. In contrast, it remained at ∼33◦Ci n
the control conditions throughout the 20min incubation
period. In the heated samples, the time needed to induce
a signiﬁcant elevation in ATP release from RBCs was
5min and did not increase any further for the rest
of the 20min incubation time (Fig.2). However, when
comparingdifferencesbetweenconditionsduringtheﬁrst
5min(n=10),ATPreleasewassigniﬁcantlyelevatedat1,3
and5minat41–42◦Ccomparedwithsamplesmaintained
at 33◦C( P ranged from 0.023 to 0.001).
C o n v e r s e l y ,w h e ns a m p l e sh e a t e dt o4 2 ◦C for 20min
were moved to a water bath set at 33◦C, ATP release
dropped sharply, so that after 10min it was back to
similar levels of ATP found in samples that remained
at 33◦C (Fig.3). These continued to remain stable after
15min and, in further samples, even after 60min (data
not shown). Normalization of the data to the numbers
of RBCs demonstrated that at 33◦C the ATP release was
1.6±0.2μmol per 108 RBCs, while heating to 42◦CA T P
release was increased to 3.4±0.4μmol per 108 RBCs
(P =0.033). No difference in the number of red cells
was observed after heating at 42 compared with 33◦C
(i.e. 3.7±0.4×109 versus 3.7±0.2×109 RBCsml−1,
respectively; P =0.84).
Effect of ATP channel and transporter blockers on
temperature-dependent release of ATP from RBCs
An attempt to block the heat-induced ATP release from
RBCs was carried out using 100, 200 and 400μmoll−1
doses of niﬂumic acid. This was conducted at a
temperature of 39◦C, evoking a more than threefold
increase in ATP release compared with the control
conditions at 33◦C (Fig.4). Incubation of RBCs with
different concentrations of niﬂumic acid at 33◦C for
20min did not alter the release of ATP, and values
were comparable to control (Fig.4A). In the presence of
increasing concentrations of niﬂumic acid, heat-induced
ATP release was signiﬁcantly attenuated by 68±6t o
91±6% (Fig.4A;a l lP<0.01).
Use of the band3 transporter inhibitor DIDS did not
inhibit the heat-induced ATP release from RBCs even
at the highest concentration of 400μmoll−1 (P<0.05;
Fig.4B), nor did DIDS increase temperature-mediated
ATP release, despite its signiﬁcant effect on ATP release
at 33◦C at the two higher concentrations, possibly due to
haemolysis (Table3). In contrast, there was a slight but
not signiﬁcant 18±6% inhibition of ATP release in the
presence of the nucleoside inhibitor NBTI. In contrast
Table 2. Haematological responses after heating whole blood samples at different
temperatures
Water bath temperature (◦C)
Variables Initial 33 36 39 42
RBCs (× 106 μl−1)5 .2 ± 0.15 .1 ± 0.15 .1 ± 0.15 .1 ± 0.15 .2 ± 0.1
Hb (g l−1) 155 ± 2 154 ± 1 155 ± 3 152 ± 4 156 ± 1
Haematocrit (%) 44.2 ± 0.54 4 .0 ± 0.34 3 .7 ± 0.94 3 .4 ± 1.14 4 .4 ± 0.3
MCV (ﬂ) 85.4 ± 0.58 5 .5 ± 0.28 5 .8 ± 0.18 5 .8 ± 0.18 5 .9 ± 0.1
MCH (pg) 30.1 ± 0.13 0 .0 ± 0.13 0 .3 ± 0.13 0 .2 ± 0.13 0 .2 ± 0.1
MCHC (g l−1) 352 ± 1 351 ± 1 353 ± 1 352 ± 1 352 ± 2
Values are means ± SEM from one individual tested eight times. Abbreviations: RBC, red
blood cells; Hb, total haemoglobin concentration; MCV, mean cell volume; MCH, mean cell
haemoglobin; and MCHC, mean corpuscular haemoglobin concentration.
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to DIDS, no signiﬁcant changes in free haemoglobin were
observedwithniﬂumicacidorNBTI,ateither33or39◦C.
Effect of CFTR inhibition with glibenclamide on
temperature-dependent release of ATP from RBCs
To assess the involvement of CFTR on temperature-
sensitive ATP release, RBCs were incubated in the
presence of glibenclamide. In the same samples of
RBCs, the effect of 400μmoll−1 niﬂumic acid was also
demonstrated. Both glibenclamide and niﬂumic acid
completely blocked the release of ATP (P<0.05; Fig.5).
Similartoniﬂumicacid,adose-dependentinhibitionwith
was observed glibenclamide, with a reduction starting
at 100, 200 and 400μmoll−1 (data not shown). Free
haemoglobin levels in the presence of either niﬂumic acid
or glibenclamide were unchanged at both 33 and 39◦C
(∼0.1±0.01gl−1).
Figure 2. Time-dependent release of ATP from red blood cells
(RBCs)
Samples heated to 42◦C were compared with samples
maintained at a constant temperature of 33◦C( A). The
temperature of RBC samples incubated in water baths set at 33
and 42 ◦C( B). Data are shown as mean ± SEM, n =6 .
∗
Signiﬁcantly different from 0 min, P < 0.01. † Signiﬁcantly
higher than 33◦C, P < 0.05.
Abundance of CFTR protein in RBCs subjected to
heating
To conﬁrm the involvement of CFTR in temperature-
dependent ATP release, protein abundance in ghost
membranes was assessed by ELISA. In RBCs heated at 33
and 42◦C isolated from blood from six individuals, CFTR
abundance increased by 42±14% (P<0.05; Fig.6).
Proteindeterminedbybicinchoninicacidassayconﬁrmed
thattheconcentrationsoftotalproteininghostmembrane
samples incubated at 33 and 42◦C were similar (5.0±0.5
and 4.9±0.5mgml−1, respectively). Further evidence of
the effect of temperature on the abundance of CFTR in
RBCmembraneswasobserv edwhensamplesw er ec ooled
down to 33◦C for 15min after heating at 42◦C for 20min.
The CFTR abundance in these samples prepared from
blood taken in two individuals declined towards control
values.
Effect of increases in temperature on arterial and
venous plasma ATP in vivo
Graded whole-body heating in human participants
increased quadriceps muscle temperature at rest from
35.3±0.4◦C in control conditions to 37.0±0.1◦C with
mild heating, 37.9±0.3◦C with moderate heating and
ﬁnally to 38.8±0.4◦C with severe heating. During
exercise,theequivalentvalueswere37.3±0.3◦Cincontrol
conditions 38.1±0.2◦C with mild heating, 38.9±0.3◦C
with moderate heating and 39.6±0.3◦C with severe
heating. A signiﬁcant correlation was observed between
the rise in muscle temperature and the increase in
arterial plasma ATP during both rest and exercise
(r2 =0.91; P =0.0001; Fig.7). This relationship was
attenuated in venous plasma ATP samples taken during
Figure 3. Release of ATP from RBCs with cooling after heating
Samples were heated to 42◦C for 20 min and then moved to
33◦C. Control samples remained at 33◦C throughout. Data are
shown as means ± SEM, n =6 .
∗
Signiﬁcantly higher than 33◦C,
P < 0.05.
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rest and exercise (r2 =0.61; P =0.137). Arterial or venous
plasma haemoglobin remained unchanged with graded
whole-body heating, indicating that haemolysis did not
contribute to the increase in plasma ATP (∼0.1±0.01g
l−1 for both arterial and venous samples).
Effect of increases in temperature on ATP release from
erythrocytes in arterial and venous samples in vitro
The ATP release was compared in RBCs heated in vitro at
33 or 39◦C from arterial and venous blood samples taken
in control resting conditions. The haemoglobin oxygen
saturation in the arterial and venous blood was 98.5±0.3
and 51.2±6.2%, respectively, with corresponding PO2
values of 105±1a n d3 5 ±4mmHg. The release of
Figure 4. Release of ATP in the presence of niﬂumic acid (A)o r
DIDS or nitrobenzylthioinosine (NBTI; B) from erythrocyte
samples heated to 39◦C compared with control conditions
(33◦C)
Open bars, ATP release at 33◦C; ﬁlled bars, ATP release at 39◦C.
Data are shown as means ± SEM for six subjects.
∗
Signiﬁcantly
lower than control 39◦C, P < 0.05. † Signiﬁcantly different from
each respective condition at 33◦C. # Signiﬁcantly higher than
control 33◦C, P < 0.05.
ATP was comparably increased to 1.69±0.30 and
2.26±0.53μmoll−1 (P<0.05) in both arterial and
venous samples heated at 39◦C from 0.78±0.17
and 0.65±0.09μmoll−1 at 33◦C, respectively (Fig.8).
Furthermore, the responses of both arterial and venous
RBCs to niﬂumic acid were similar, indicating that the
sensitivitiesofthetemperature-sensitiveATPtransporters
were not affected by the oxygenation status of the RBCs,
becausetheydemonstratedcompleteinhibition(P<0.05;
Fig.8).
Discussion
This study reveals six key ﬁndings that provide novel
insight into the blood source and the temperature-
sensitive mechanisms of ATP release in human red blood
cells. First, the erythrocytes were the primary source
of ATP from blood-formed elements. Second, cooling
after heating restored erythrocyte ATP release to baseline
levels. Third, heat-mediated erythrocyte ATP release was
completelyblockedbyeitherniﬂumicacid(anon-speciﬁc
ion channel inhibitor which blocks Ca2+-activated Cl−
channels)orglibenclamide(aninhibitorofCFTR)butwas
notblockedbyinhibitorsofnucleosidetransportoranion
exchange. Forth, heating the blood enhanced protein
abundance of CFTR in membrane protein fractions
isolatedfromRBCs.Fifth,invitroﬁndingswereconsistent
with the progressive increase in arterial plasma ATP
observed in vivo in resting and exercising heat-stressed
humans. Sixth, in vitro, however, the increase in ATP
release from RBCs was similar in arterial and venous
samples, suggesting that the lower in vivo rate of increase
in venous plasma ATP with temperature might be due
to increased ATP degradation. These ﬁndings collectively
demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature via CFTR-
like channels and imply the existence of a potentially
importantmechanismforcontroloflocaltissueperfusion
in conditions of elevated blood and tissue temperature.
Source of temperature-dependent ATP release in
human blood
A key aim of the present study was to identify the source
of ATP release from blood components. With this aim,
we used an in vitro experimental set-up that excluded
the potential confounding inﬂuences of endothelial and
sympathetic nerve-derived ATP. The temperatures used
to heat whole blood, RBCs, plasma and serum (33–
42◦C; Fig.1) cover the normal physiological temperature
range found in the human blood and muscle tissue
during exposure to environmental heat stress, external
heating and/or exercise (Saltin et al. 1972; Gonz´ alez-
Alonso et al. 1999a,b). In the present in vivo study
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Table 3. Free haemoglobin levels in bathing solution after heating erythrocytes treated with niﬂumic acid, DIDS and
nitrobenzylthioinosine (NBTI)
Haemoglobin (g l−1)
Niﬂumic acid (μmol l−1)D I D S ( μmol l−1) NBTI (nmol l−1)
Temperature (◦C) Control 100 200 400 100 200 400 50
33 0.15 ± 0.01 0.17 ± 0.02 0.16 ± 0.02 0.13 ± 0.02 0.13 ± 0.03 0.25 ± 0.04
∗
0.32 ± 0.05
∗
0.16 ± 0.03
39 0.09 ± 0.01 0.17 ± 0.03 0.16 ± 0.02 0.13 ± 0.01 0.16 ± 0.02 0.22 ± 0.02
∗
0.32 ± 0.04
∗
0.13 ± 0.02
Data are shown as means ± SEM, of n =6 .
∗
Signiﬁcantly different from control value P < 0.05.
speciﬁcally, quadriceps muscle temperature ranged from
34◦C in the resting control conditions to 41◦Cd u r i n g
combined heat stress and knee-extensor exercise (Fig.7).
Thus,thedesignofthisstudyalsoallowedthecomparison
of the effect of graded increases in temperature on ATP
release from whole blood and its individual constituents
in vitro to the effect of whole-body heating in vivo.
An important observation of this study was that ATP
release from heated whole blood in vitro was signiﬁcantly
elevated and, interestingly, reached comparable levels to
those found in the arterial plasma in vivo even though
the experimental conditions were vastly different. A
critical question is, which blood constituent accounts
for the increase in ATP? To answer this question, heat-
induced ATP release was measured from RBCs, plasma
and serum samples. We observed that ATP release from
RBCsincreasedprogressivelywithtemperature(r2 =0.96;
P =0.021) to levels higher than in whole blood or in
plasma during in vivo heating and exercise. In contrast,
heating plasma or serum did not elevate the free ATP
Figure 5. Release of ATP by venous erythrocyte samples heated
to 39◦C compared with control conditions (33◦C) in the
presence of 400 μmol l−1 niﬂumic acid (NFA) or 400 μmol l−1
glibenclamide (GLIB)
Open bars, ATP release at 33◦C; ﬁlled bars, ATP release at 39◦C.
Data are shown as means + SEM for nine subjects.
∗
Signiﬁcantly lower than control 39◦C, P < 0.05. † Signiﬁcantly
different from control conditions at 33◦C.
concentration with increasing temperature from 33 to
42◦C( F i g . 1 C.). However, and in contrast to whole
blood, RBCs and plasma, a signiﬁcant fall in serum
ATP was observed from the initial basal concentration
of 0.215μmoll−1 to >0.019μmoll−1 at all temperatures.
This indicates the presence of a high level of ATP
catabolic activity within the serum fraction in the
form of the soluble enzymes nucleoside triphosphate
diphosphohydrolase(NTPDase; knownas ecto-ATPDase,
CD39),nucleotidepyrophosphatase(NPP)andhydrolase
plus ecto-5 -nucleotidase (Yegutkin et al. 2003), which
all work together to break down ATP. The difference in
catalytic activity of plasma ecto-5 -nucleotidase might
account for the drop in ATP levels in serum and the
maintenanceofATPincell-freeplasma(Coade&Pearson,
1989).
Critical to the interpretation of the present ﬁndings
is whether the observed increase in plasma or ‘bathing
solution’ ATP with elevations in temperature is due
to haemolysis and thus contamination from the higher
Figure 6. ELISA analysis of the binding capacity of CFTR on
protein isolated from RBC ghost membranes heated at 42◦C
relative to 33◦C (control)
Open bars, CFTR binding at 33◦C; ﬁlled bars, CFTR binding at
42◦C. Data are shown as means ± SEM for six subjects.
∗
Signiﬁcantly different from 33◦C (control).
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intracellular ATP concentration in RBCs. To avoid this
possibility, blood samples were handled carefully while
centrifuging and pipetting, and the isolation procedure
did not include a wash step or resuspension step in a
buffer solution. In our study, plasma or ‘bathing solution’
free haemoglobin concentration remained unchanged
with increases in temperature from 33 to 42◦Ci n
RBC preparations (Table1) and thus the temperature-
dependent increase in ATP was not correlated to free
haemoglobin (r2 =0.48; P =0.921). Furthermore, RBC
count, mean cell volume, mean cell haemoglobin and
mean corpuscular haemoglobin concentration did not
change, further suggesting that the rise in temperature
did not affect the volume and integrity of the blood
Figure 7. Relationship between quadriceps muscle
temperature and plasma ATP
Whole-body heat stress increases arterial plasma ATP levels with
both rest and exercise (r2 = 0.91; P < 0.0001). No signiﬁcant
relationship was observed between venous plasma ATP levels
and muscle temperature (r2 = 0.61; P = 0.14). Open triangles
represent rest, whereas closed triangles represent exercise
measurements. Data are means ± SEM for 10 subjects.
cells. In addition, we reason that if the ATP release
was due solely to haemolysis, rather than a transport-
mediated process, it would not respond to any blocking
agent. In support of a transport-mediated process, we
found that ATP release was completely blocked with
400μmoll−1 niﬂumicacidor400μmoll−1 glibenclamide
at 39◦C( F i g s4 A, 5 and 8). Therefore, the short time for
which the erythrocytes were exposed to temperatures of
>36◦C in the present study did not cause any statistically
signiﬁcant haemolysis. Moreover, any remaining plasma
and serum in the RBC fraction would contribute very
little to the observed fourfold increase in heat-induced
releaseofATPfromRBCs(Fig.1C andD).Takentogether,
these ﬁndings demonstrate that the sole blood source of
temperature-dependent ATP release is the erythrocytes,
andthecontributionfromotherelementswithintheblood
is negligible.
Another key question is, how rapidly does temperature
increase ATP release from erythrocytes? As a ﬁrst attempt
to answer this question, we heated the RBC solutions to
∼42◦Cfordifferentdurations(1,3,5,10and20min)and
comparedresultswithcontrolconditionsat∼33◦C.Inthis
experimental setting, we observed a signiﬁcantly higher
[ATP] in the ‘bathing solution’ after 1min of incubation
at ∼42 compared with ∼33◦C and a signiﬁcant increase
in ATP over time after 5min in the heated conditions.
Although studies measuring ATP release in real time with
Figure 8. Release of ATP from arterial and venous erythrocyte
samples heated to 39◦C compared with control conditions
(33◦C) in the presence of 400 μmol l−1 NFA
Grey bars, arterial ATP release at 33◦C; open bars, venous ATP
release at 33◦C; grey hatched bars, arterial ATP release at 39◦C;
ﬁlled bars, venous ATP release at 39◦C. Data are shown as
means ± SEM for four subjects. Signiﬁcantly different from
venous initial. † Signiﬁcantly higher than venous initial, venous
control at 33◦C, venous NFA at 33◦C and venous NFA at 39◦C.
# Signiﬁcantly lower than arterial control at 39◦C.
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sensorsspeciﬁcforATParerequiredtoassessthetemporal
response to heating more precisely (Llaudet et al. 2005),
webelievethattheobserveddifferencesinATPafter1min
of heating might have important regulatory implications
in vivo. For instance, in our recent isolated leg heating
study (Pearson et al. 2011) the leg blood ﬂow increased
progressively from 0.5±0 . 1t o1 . 0±0.1lmin−1 over the
1h heating protocol, which was closely associated with
the gradual increase in muscle temperature.Moreover, we
have previously shown that a very low ATP infusion rate
of 200nmolmin−1 into the femoral artery, which does
not change plasma [ATP], can increase leg blood ﬂow by
1lmin −1 (Gonz´ alez-Alonso et al. 2002). It is therefore
reasonable to suggest that increases in intravascular ATP
have the potential to contribute to the vasodilatation in
the vasculature of the leg tissue seen during local heating
in vivo. Another important observation of this study was
the effect of cooling after heating, showing that ATP
release gradually returned to control values (Fig.3). This
further supports the suggestion that heating per se does
not disturb the integrity of the RBCs or the functioning
of the ATP channels, and thus erythrocyte ATP release is a
true physiological response triggered by heating.
Mechanisms of temperature-dependent ATP release
from human erythrocytes
The present ﬁndings demonstrate that temperature is
an important physiological stimulus for the release of
ATP from human erythrocytes. A second aim of this
study was to gain insight into the temperature-sensitive
mechanisms of ATP release. There are several possible
pathways by which temperature might operate. First,
increases in temperature could affect the ﬂuidity of the
erythrocytemembrane,whichinturncouldalterthelipid
and protein interactions and increase permeability for
ATP and other molecules. Although this is a reasonable
possibilitywhenexposingRBCstoveryhightemperatures
(i.e. >48◦C), its relevance at the temperatures used in
this study (33–42◦C) seems to be minimal (Williamson
et al. 1975), because temperature-mediated erythrocyte
ATP release was completely blocked with either niﬂumic
acid or glibenclamide, despite the persistent high
temperature, and was fully restored with application of
cooling after heating. Second, ATP could be released
by diffusion down a gradient, because the intracellular
concentration of ATP in RBCs is ∼2mmoll−1,w h e r e a s
the plasma concentration in resting humans is normally
in the nanomolar range (Gonz´ alez-Alonso et al. 2002;
Rosenmeier et al. 2004; Yegutkin et al. 2007; Dufour
et al. 2010; Mortensen et al. 2011). However, this is also
an unlikely possibility, because ATP is a large, charged
molecule and thus would not easily cross the cellular
membrane(Gordon,1986).Athird,morelikelypossibility
is that an active transporter or channel is responsible for
thecontrolled,temperature-dependentmovementofATP
out of the erythrocyte.
Release of ATP from erythrocytes has been proposed
to involve membrane-bound ion channels, gap junction
proteins, such as pannexin1, and/or the ATP-binding
cassette proteins, such as CFTR (Bergfeld & Forrester,
1992; Abraham et al. 1993; Locovei et al. 2006). There
are three observations in the present study that provide
strongsupportfortheinvolvementofCFTRorCFTR-like
channels. First, we found that the temperature-mediated
erythrocyte ATP release was completely blocked with the
inhibitors of Ca2+-activated Cl− channels niﬂumic acid
andglibenclamide(aCFTRinhibitor),butnotwithDIDS.
This suggests the involvement of a Cl− channel that is
insensitive to DIDS, contrary to the study by Bergfeld &
Forrester (1992). The solubility of the different blockers
could be increased by temperature, and other unspeciﬁc
properties, such as lysis caused by DIDS, could be
resolved by washing away and then measuring the effects.
However, the temperature-sensitive channel proposed in
the present study could be similar to the erythrocyte
channel stimulated by deformation, also thought to be
CFTR, because both niﬂumic acid and glibenclamide
inhibited ATP release (Sprague et al. 1998). Furthermore,
previous work has demonstrated that niﬂumic acid can
also directly block the CFTR channel by inhibiting the
permeation of Cl− currents by plugging the channel
pore (Scott-Ward et al. 2004). Second, the presence of
NBTI did not block the heat-mediated ATP release from
the erythrocytes. This provides further evidence that the
temperature-sensitive channels in erythrocytes are not
affected by inhibitors of either nucleoside transport or
anion exchange (Bergfeld & Forrester, 1992). Finally,
CFTR protein abundance was increased, possibly due to
temperature-induced trafﬁcking to the cell membrane or
demaskingofepitoperegions,becauseerythrocytesdonot
have the necessary tools for protein synthesis (Denning
etal.1992;Chengetal.2010).Thistemperature-mediated
CFTR translocation or activation could facilitate the
transport of ATP out of the RBCs. This is consistent with
the observation that ATP release induced by decreasing
pH also increased CFTR abundance in isolated skeletal
muscle cells (Tu et al. 2010). Taken as a whole, these
observations indicate that the increase in temperature-
stimulated erythrocyte ATP release might involve the
activation of erythrocyte CFTR or CFTR-like channels.
An alternative physiological mechanism that could
play a part in promoting the release of ATP when
temperatureisincreasedistheshiftintheoxyhaemoglobin
dissociation curve (Barcroft & King, 1909; Duc &
Engel, 1969). A rightward shift of the curve reﬂects a
reduction in the afﬁnity of haemoglobin for oxygen that
could lead to an augmented oxygenation-coupled ATP
release from erythrocytes. Pioneering work demonstrated
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that erythrocytes release ATP in response to hypoxia
or independent reductions in PO2 and haemoglobin
oxygenation (Bergfeld & Forrester, 1992; Ellsworth et al.
1995; Sridharan et al. 2010). An important question is
therefore whether the presently observed increases in
erythrocyte ATP release with progressive elevations in
temperatureareinﬂuencedbytheoxygenationstateofthe
haemoglobin molecule and parallel changes in PO2.T h e
evidence from our study suggests that the temperature
stimulusforerythrocyteATPreleasediffersfromthewell-
characterized stimulus coupled to the fall in PO2 and
oxyhaemoglobin (Ellsworth et al. 1995). For instance,
the parallel observation that femoral venous oxygenation
and PO2 increased during whole-body heating in vivo
accompanying an elevation of leg tissue blood ﬂow, but
arterialoxygenationremainedunchangedandarterialATP
increased gradually with the rise in muscle temperature
(Pearson et al. 2011), supports a pathway of ATP release
that is independent of reductions in blood oxygenation.
This notion is further supported by the present in vitro
observationshowingsimilarinitialandcontrolATPlevels
in arterial and venous plasma despite large differences
in haemoglobin oxygen saturation and PO2 (i.e. 98 versus
55%and105±1versus35±4mmHg).Furthermore,any
differences with regard to afﬁnity of arterial or venous
blood to the presence of niﬂumic acid were not apparent,
because they were both equally blocked to prevent heat-
induced ATP release. Taken together, the present ﬁndings
highlight a novel mechanism of temperature-dependent
ATP release from erythrocytes, which is independent of
the oxygen ofﬂoading from the haemoglobin molecules.
Physiological implications for the control of local
tissue perfusion
Thisstudyprovidesaninsightintoapotentialmechanism
involved in the local control of blood ﬂow during
conditions of increasing blood and tissue temperature,
such as exposure to heat stress, exercise, fever or thermal
therapy. Although increases in limb blood ﬂow with heat
stress have generally been thought to be the sole response
to an augmented thermoregulatory demand of the skin
circulation (Rowell, 1974), evidence in pigs and humans
shows that skeletal muscle blood ﬂow is also increased
with local and whole-body heating (Akyurekli et al. 1997;
Keller et al. 2010; Pearson et al. 2011), a response that is
closely related to the rise in local muscle temperature and
thearterialplasmaconcentrationofATPduringheatstress
at rest and during exercise (Pearson et al. 2011). Knowing
that muscle and capillary blood temperatures are similar
due to rapid temperature equilibration (He et al. 2002),
our parallel and present observations indicate that local
hyperthermia induces vasodilatation through increases in
intravascular ATP and/or other vascular signals sensitive
to temperature. ATP is an attractive mediator signal for
skeletal muscle blood ﬂow control, because not only can
it act as a potent vasodilator, but also it has sympatholytic
properties in the leg and forearm (Rosenmeier et al. 2004;
Kirby et al. 2008), which are required to maintain or
increase perfusion in conditions of augmented muscle
sympathetic nerve activity, such as heat stress and
exercise (Niimi et al. 1997; Ray & Gracey, 1997; Pearson
et al. 2011).
Thetemperature-dependentmechanismofATPrelease
from human erythrocytes documented in this study
opens the possibility of using external heating as a
non-pharmacological means of increasing limb tissue
perfusion, including that to skeletal muscle, in diseases
characterized by limb ischaemia. It is known that
circulatoryproblemsassociatedwithageingandanumber
of diseases, such as diabetes and peripheral vascular
disease, could beneﬁt from increasing ﬂow to limb tissues
that become deprived of oxygen and substrates (Feliciano
& Henning, 1999; Schrage et al. 2007; Black et al. 2008;
Kirby et al. 2010; Ruiter et al. 2010). Although decreased
cell-to-cell communication along vascular endothelium,
changes in receptor expression or damaged endothelium,
and impaired smooth muscle function could potentially
blunt the limb tissue hyperaemic response to heating
in some patient populations, studies using thermal
therapy or ‘forearm heat training’ have shown profound
muscle hyperaemia and beneﬁcial endothelial adaptive
responses (Akyurekli et al. 1997; Green et al. 2010). It
would therefore be interesting to extend these studies by
investigating whether limb heating enhances ATP release
fromerythrocytesandincreasesskeletalmusclebloodﬂow
in elderly people and different patient populations with
circulatory dysfunction.
In summary, our in vitro and in vivo ﬁndings
demonstrate that erythrocyte ATP release is sensitive
to physiological increases in temperature independent
of oxygenation, possibly by activation of a CFTR-like
channel. These data have potential clinical implications
for the treatment of patients with peripheral vascular
disease non-pharmacologically, by using local heating
to stimulate erythrocyte ATP release and thus increase
ﬂow and oxygen and substrate supply to limb
tissues.
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